Evidence map›Paper›PMID 37314177›Full record

Trial reportAnnals of surgery2023

Efficacy of Immediate Lymphatic Reconstruction to Decrease Incidence of Breast Cancer-related Lymphedema: Preliminary Results of Randomized Controlled Trial.

Michelle Coriddi, Joseph Dayan, Emily Bloomfield, Leslie McGrath, Richard Diwan, Jasmine Monge, Julia Gutierrez, Stav Brown, Lillian Boe, Babak Mehrara

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Annals of surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 2 pooled it
21.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 2 syntheses or guidelines pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Lymphovenous Bypass: Past, Present, and Future.Archives of plastic surgery · 2026
    Article
  10. Observational
  11. Article
  12. Article
  13. Review
  14. Observational
  15. Article
  16. Review
  17. Article
  18. William Halsted's Radical Mastectomy Patients: A Historical Analysis Through Patient Narratives.Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2026
    Article
  19. Article
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Michelle CoriddiPlastic & Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Joseph DayanPlastic & Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Emily BloomfieldPlastic & Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Leslie McGrathPlastic & Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Richard DiwanPlastic & Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Jasmine MongePlastic & Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Julia GutierrezPlastic & Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Stav BrownPlastic & Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Lillian BoeBiostatistics Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
Babak MehraraPlastic & Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Mechanisms of fibrosis in post-surgical lymphedemaR01HL111130 · NHLBI · SLOAN-KETTERING INST CAN RESEARCH · PI MEHRARA, BABAK J · 2012 to 2021
$7.2M
Mechanisms of racial disparity in breast cancer-related lymphedemaR01CA278599 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Andrea Barrio, Babak J Mehrara · 2023 to 2026
$2.9M
Molecular mechanisms of age-related lymphatic dysfunctionR21AG076132 · NIA · SLOAN-KETTERING INST CAN RESEARCH · PI MEHRARA, BABAK J · 2022 to 2023
$487k
Role of epidermis in regulating inflammatory skin manifestations of post-surgical lymphedemaR21AR081076 · NIAMS · SLOAN-KETTERING INST CAN RESEARCH · PI MEHRARA, BABAK J · 2023 to 2024
$422k
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA278599NHLBI NIH HHS R01 HL111130NIAMS NIH HHS R21 AR081076NIA NIH HHS R21 AG076132
6 · The paper itself

Abstract

objectiveTo conduct a randomized controlled trial (RCT) on the efficacy of immediate lymphatic reconstruction (ILR) for decreasing the incidence of breast cancer-related lymphedema (BCRL) after axillary lymph node dissection (ALND).

backgroundDespite encouraging results in small studies, an appropriately powered RCT on ILR has not been performed.

methodsWomen undergoing ALND for breast cancer were randomized in the operating room 1:1 to either ILR, if technically feasible, or no ILR (control). The ILR group underwent lymphatic anastomosis to a regional vein using microsurgical techniques; control group had no repair and cut lymphatics were ligated. Relative volume change (RVC), bioimpedance, quality of life (QoL), and compression use were evaluated at baseline and every 6 months postoperatively up to 24 months. Indocyanine green (ICG) lymphography was performed at baseline and 12 and 24 months postoperatively. The primary outcome was the incidence of BCRL, defined as ≥10% RVC from baseline in the affected extremity at 12-, 18-, or 24-month follow-up.

resultsOf 72 patients randomized to ILR and 72 to control from January 2020 to March 2023, our preliminary analysis includes 99 patients with 12-month follow-up, 70 with 18-month follow-up, and 40 with 24-month follow-up. The cumulative incidence of BCRL was 9.5% in the ILR group and 32% in the control group ( P =0.014). The ILR group had lower bioimpedance values, decreased compression usage, better lymphatic function on ICG lymphography, and better QoL than the control group.

conclusionsPreliminary results of our RCT show that ILR after ALND decreases BCRL incidence. Our goal is to finish the accrual of 174 patients with 24-month follow-up.

Indexed as

Breast Cancer LymphedemaBreast NeoplasmsLymphedemaAxillaFemaleHumansIncidenceIndocyanine GreenLymph Node ExcisionIndocyanine Green

Identifiers

PMID37314177
PMCPMC10527595
OpenAlexW4380577707

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.